PGx News

<< First  < Prev   1   2   3   4   Next >  Last >> 
  • Thu, April 06, 2023 5:55 PM | Liam Dalrymple (Administrator)

    Meet Dr. Britt Drögemöller Assistant Professor at the Department of Biochemistry & Medical Genetics, University of Manitoba, and Canada Research Chair in Pharmacogenomics and Precision Medicine.

    Dr Drögemöller kindly answered to a few questions we were curious to know about.

    Q: How long have you been a member of the PGRN?
    I joined the PGRN (as a trainee member) in 2017.

    Q: How has the PGRN helped your career in pharmacogenomics?

    A: Joining the PGRN has created several professional development and net

    working opportunities for me. By attending PGRN meetings as a trainee, I was able to present my research and meet pharmacogenomics researchers from around the world. This created an ideal environment to build up collaborations that have continued to grow along with my career. These connections were extremely valuable as I started my own group, and I am thrilled to see my own trainees taking advantage of PGRN opportunities like the mentorship program, so that they can grow their own networks.

    Q: What is your current position/role?
    A: I am an Assistant Professor in the Department of Biochemistry and Medical Genetics at the University of Manitoba and a Canada Research Chair in Pharmacogenomics and Precision Medicine.

    Q: What do you enjoy most about your current position?
    A: As a human geneticist, I am really excited about the vast amounts of genomics data that are being generated, which can be used to advance precision medicine research. Beyond being fortunate enough to be in a position where I can focus on this growing area of research, I enjoy the creative process of working together as team. There is nothing more rewarding than meeting to brainstorm specific aspects of a project, and to see how each individual provides a new perspective on how to approach a problem. I am so fortunate to have such a talented group of individuals working in the lab and we are always looking for more passionate individuals to join our team.

    Q: You are a member of the PGRN Oncology Special Interest Group; what are the topics/goals within this group that you’re most interested in?
    A: As the lead of the Collaborative Cancer Pharmacogenomics Research Subcommittee, I am particularly excited about creating opportunities to foster collaboration between PGRN members around the globe. We are in the process of creating searchable databases so that researchers can easily identify sources of data and collaborators in their specific areas of research. Our primary aim is for these resources to enable the generation of collaborative outputs for PGRN members.

    Q: What do you see as the most exciting advances in pharmacogenomics over the next 2-5 years?
    A: I think there are many exciting avenues for pharmacogenomics research, which have been enabled by rapid advances in genomic technologies. The detailed insights that can be achieved by combining single cell sequencing technologies with high throughput genomic analyses, will provide us with unprecedented opportunities to identify drug targets. This will ultimately lead to the development of more precise therapeutics and better treatment outcomes for diverse individuals around the globe.

  • Wed, November 23, 2022 2:32 PM | Matt Riley (Administrator)

    Meet Dr. Sara Van Driest, MD, PhD, Director of Pediatrics for the All of Us Research Program.

    1. How long have you been a member of the PGRN?

    I am a founding member of the PGRN; I think Jason Karnes and I were among the very first to sign up during the call that announced the existence of the organization! I was also involved with the PGRN when it was an NIH-funded network, starting when I joined Dan Roden’s lab as a fellow in 2010.

    2. How has the PGRN helped your career in pharmacogenomics?

    PGRN has consistently exposed me to high quality pharmacogenomic research, cutting edge findings, and glimpses of the future of the field. More importantly, it also catalyzed my relationships with collaborators and provided me with so many excellent role models at all stages of my career.

    3. What is your current position/role?

    I recently started in a new position as the Director of Pediatrics for the All of Us Research Program at the National Institutes of Health. My job is to lead efforts in the program to engage pediatric participants in the cohort.

    4. What do you enjoy most about your current position?

    It has been incredibly inspiring and encouraging to meet my teammates at All of Us. They are an extremely bright and passionate group of individuals, which is important since we are trying to do some really difficult and important things.

    5. What do you see as the most exciting advances in pharmacogenomics over the next 2-5 years?

    I am most excited about the increasing commitment by individuals, institutions, and programs to be more inclusive, diverse, and equitable in every aspect of pharmacogenomics (including in the All of Us Research Program). This focus will lead to incredible scientific insights, decrease health disparities, and provide an example for other areas of science and medicine!

  • Wed, November 23, 2022 12:55 PM | Matt Riley (Administrator)

    The PGRN Early Career Committee is pleased to announce the launch of the 2022-2023 PGRN Mentoring Program. The program will begin officially on December 1 and will match experienced scientists with early career scientists and trainees in the pharmacogenomics field. We ask that mentors and mentees meet monthly over the next six months, ideally culminating with an in-person meeting at the PGRN Annual Meeting. Please use the links below to participate as either a mentee or a mentor by Wednesday, November 30.

    Following feedback from last year’s program, we have made several improvements. There is now a formal mentoring agreement associated with the program to increase the productivity of these mentoring relationships. Mentees should consider this survey an application for participation in the program. Mentees should also create a 250-500 word statement of interest for the program to be submitted with their survey. The statement of interest should describe your ultimate objectives for the PGRN Mentorship Program, as well as consider your goals for the next 6 months and how you believe having a PGRN Mentor may help you achieve them.

    Mentees Click Here to Apply

    Mentors Click Here to Volunteer

    Important: Please also be sure to complete all information on your member profile, which we will use to facilitate matching. Log in

    Thank you,
    PGRN Early Career Committee

  • Wed, November 23, 2022 12:25 PM | Matt Riley (Administrator)

    The Psychiatry Special Interest Group meets every two months and aims to bring together scientists from all over the world working in academia and industry and interested in the exciting and emerging field of Psychiatric Pharmacogenomics.

    The next Pharmacogenetics in Psychiatry Interest Group meeting will be held on December 1, 2022 12:00 – 2:00 PM Eastern Time (US and Canada)

    (Zoom link available via:

    Assoc. Prof. Marin Jukić, PharmD
    University of Belgrade - Pharmacy school, Serbia
    Karolinska Institute, Stockholm, Sweden

    Title: Role of polymorphic CYP2C19 and CYP2D6 enzymes in psychiatric phenotypes and psychiatric drug metabolism

    Biography: Dr. Marin Jukić earned an MSc degree in pharmacy at the University of Belgrade, Serbia, completed his PhD in neuroscience at Ben Gurion University, Israel, and received postdoctoral training at Karolinska Institute, Sweden. Marin is currently employed as an associate professor at the University of Belgrade and a senior researcher at Karolinska Institute. Dr. Marin Jukić research is focused on brain development, monoaminergic neurotransmission, neuropsychopharmacology, and pharmacogenetics in psychiatry.

  • Mon, October 24, 2022 11:41 AM | Matt Riley (Administrator)

    Dear colleagues,

    I am happy to announce that our 2023 annual scientific meeting will be in-person on June 12th and 13th in Memphis Tennessee. Held on the campus of St. Jude Children’s Research Hospital, this meeting will include a full-day scientific program on the 12th and followed by a half-day for ancillary workshops and other PGRN events on the 13th. Our Scientific Committee led by Erica Woodahl and Marisa Medina is working hard to flesh out the program with a fantastic line-up of speakers and activities.

    Please mark your calendar for this important PGRN event and stay tuned for more details.

    Best regards,

    Jun J. Yang PhD
    President, PGRN

  • Fri, October 21, 2022 5:47 PM | Matt Riley (Administrator)

    Dr. Sara van Driest has recently accepted a position with All of Us at NIH. To avoid potential conflict of interest, she also resigned as the PGRN secretary. While we are sad to lose her, we look forward to working with her in her new capacity to advance pharmacogenomics research in pediatric populations.

    After careful consideration, the PGRN council asked Dr. Erica Woodahl to fill the Secretary vacancy on the Board for the remainder of the year, and she has graciously agreed. Dr. Woodahl’s appointment will start immediately and this position will be open for election in mid 2023 when she will run as the incumbent.

    Please join me in welcoming Dr. Woodahl to the Board and also thanking Dr. van Driest for her service to PGRN.

    Jun J. Yang PhD
    President, PGRN

<< First  < Prev   1   2   3   4   Next >  Last >> 

Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.

PGRN is a 501(c)3 Non-Profit Association

Follow PGRN
on Social Media

Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Join your colleagues today and suport the work of PGRN. 
Powered by Wild Apricot Membership Software